Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm Metastasis
Interventions: DRUG: Pamidronate
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Novartis